Otolaryngology Doctors in Bel Air, MD Accepting Medicare

8 Otolaryngology doctors found. Showing 1 - 8

Dr. Clarence Winfred Gehris Jr., M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Dr. Michael Porter Rodrigues, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Drive, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Mr. Leonard R Proctor, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Dr. Philander Bowen Briscoe, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Dr. Nancy L Solowski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Dr. Carla Michelle Lawson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

Dr. David James Hoyt, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4 A North Ave, Suite202, Bel Air, MD 21014 Phone: 410-420-0057    Fax: 410-420-0071

Dr. Katherine Virginia Day, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr, Suite 206, Bel Air, MD 21014 Phone: 410-879-9100    Fax: 410-879-0227

News Archive

Non-invasive accurate blood test for prostate cancer

For men, one of the most dreaded moments could be hearing, "We're not yet sure, but your PSA is high; you'll have to come for further tests." This could start a chain of events which ends in the diagnosis of prostate cancer - including a prostate biopsy, and ending in a major surgery for prostate removal.

Study explores potential of program designed to prevent avoidable rehospitalizations

Recent federal legislation imposes financial penalties on hospitals that experience excessive patient readmissions within 30 days. A new study published today in the Journal of Hospital Medicine looks at the potential of a program designed to improve the discharge process and prevent avoidable rehospitalizations.

Gene variations may increase risk of developing schizophrenia: Study

By analyzing the genomes of patients with schizophrenia, genetics researchers have discovered numerous copy number variations—deletions or duplications of DNA sequences—that increase the risk of developing schizophrenia. Significantly, many of these variations occur in genes that affect signaling among brain cells.

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the AdV HALT Trial (A Randomized, Placebo-Controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation [HSCT]).

Research to improve prognosis for patients with dementia and Alzheimer's disease

Research on preventing the devastating onset of dementia is about to break new ground as McGill University, in partnership with Pfizer Canada, has announced today the creation of a professorship for the prevention of dementia and Alzheimer's-related diseases.

Read more Medical News

› Verified 9 days ago